Here’s my summary of our current knowledge about extraintestinal pathogenic Escherichia coli and the challenges and opportunities associated with vaccine development for these bacteria.
Preventive measures such as vaccination are strong antimicrobial stewardship tools that need more development so the attention is not focused only on the development of new antibiotics. Here are my thoughts on the current landscape of vaccines against extraintestinal pathogenic Escherichia coli.
Extraintestinal pathogenic E coli (ExPEC) has been around for a long time and will likely remain clinically important in the foreseeable future. Read Dr David van Duin’s thoughts on why this is a concern and what populations are at highest risk for developing ExPEC invasive infections.
Learn about the diverse strains of extraintestinal pathogenic Escherichia coli (ExPEC) including pertinent virulence factors and antimicrobial resistance profiles that cause invasive disease.
Read about the prevalence of infections caused by extraintestinal pathogenic Escherichia coli (ExPEC) and the populations at highest risk for invasive disease.
Review the current landscape of vaccine development targeting extraintestinal pathogenic Escherichia coli (ExPEC) and its potential benefits for invasive disease prevention and mitigation of antibiotic resistance.
Learn from experts about extraintestinal pathogenic Escherichia coli (ExPEC) concerns, populations at risk for invasive disease and approaches to ExPEC prevention, including an overview of the current landscape of vaccine development.
Listen to expert insights on key concepts of ExPEC, including virulence factors associated with invasive disease, antimicrobial resistance profiles observed in clinical practice, populations at risk for invasive disease, and the current landscape of vaccine development.